Approval · Notice of Compliance 20089 · 2017
TOBRADEX: Notice of Compliance 20089
Issued November 27, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20089
- Date
- November 27, 2017
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate drug product manufacturing, packaging, labelling and testing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TOBRADEX | Not yet assigned | — |
Medicinal ingredients
- DEXAMETHASONE 0.1 PER
- TOBRAMYCIN 0.3 PER